Correlation Analyses of the Consumption of Artificial Sweeteners During Pregnancy and the Incidence of Gestational Diabetes Mellitus.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Li Huang, Yanling Huang, Huan Zhang, Chunmei Lyu
{"title":"Correlation Analyses of the Consumption of Artificial Sweeteners During Pregnancy and the Incidence of Gestational Diabetes Mellitus.","authors":"Li Huang, Yanling Huang, Huan Zhang, Chunmei Lyu","doi":"10.2147/DMSO.S513544","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pregnant women face a higher risk of developing gestational diabetes mellitus (GDM) due to the poor dietary habits. GDM can influence the health of both mothers and child. As food processing develops, pregnant women inevitably consume artificial sweeteners, among with the three most common are sucralose, aspartame, and sodium saccharin. It is a concern whether artificial sweeteners consumed during pregnancy increases GDM risk.</p><p><strong>Purpose: </strong>To analyze the association between artificial sweetener consumption during pregnancy and the incidence of GDM.</p><p><strong>Methods: </strong>422 pregnant women from a Guangdong hospital were surveyed through convenience sampling. The questionnaire collected general information, artificial sweeteners consumption and other GDM related factors. According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG), GDM was diagnosed was met the 75g oral glucose tolerance test (OGTT) at any time of pregnancy. The consumption of artificial sweeteners was categorized into low and high-consumption groups according to a four-point scale. A multifactorial logistic regression model was used to control for confounders and analyze the association between artificial sweetener consumption andGDM.</p><p><strong>Results: </strong>This study included 422 pregnant women with a mean age of (32 ± 3.73) years and a GDM incidence of 13.74%. The GDM incidence was higher in the high artificial sweeteners consumption group (56.90%), than in the low consumption group (43.10%) (p < 0.05). Increased artificial sweetener consumption was linked to a higher GDM risk (OR=2.66,95% CI: 1.48-1.78). High artificial sweeteners consumption was a GDM risk factor in BMI-stratified analyses.</p><p><strong>Conclusion: </strong>High consumption of artificial sweeteners, like sucralose, aspartame, and sodium saccharin, is linked to increased risk of GDM in pregnant women. Further research is required to confirm results and explore mechanism, guiding healthy eating habits during pregnancy.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"1527-1538"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12068279/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S513544","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pregnant women face a higher risk of developing gestational diabetes mellitus (GDM) due to the poor dietary habits. GDM can influence the health of both mothers and child. As food processing develops, pregnant women inevitably consume artificial sweeteners, among with the three most common are sucralose, aspartame, and sodium saccharin. It is a concern whether artificial sweeteners consumed during pregnancy increases GDM risk.

Purpose: To analyze the association between artificial sweetener consumption during pregnancy and the incidence of GDM.

Methods: 422 pregnant women from a Guangdong hospital were surveyed through convenience sampling. The questionnaire collected general information, artificial sweeteners consumption and other GDM related factors. According to the International Association of Diabetes and Pregnancy Study Groups (IADPSG), GDM was diagnosed was met the 75g oral glucose tolerance test (OGTT) at any time of pregnancy. The consumption of artificial sweeteners was categorized into low and high-consumption groups according to a four-point scale. A multifactorial logistic regression model was used to control for confounders and analyze the association between artificial sweetener consumption andGDM.

Results: This study included 422 pregnant women with a mean age of (32 ± 3.73) years and a GDM incidence of 13.74%. The GDM incidence was higher in the high artificial sweeteners consumption group (56.90%), than in the low consumption group (43.10%) (p < 0.05). Increased artificial sweetener consumption was linked to a higher GDM risk (OR=2.66,95% CI: 1.48-1.78). High artificial sweeteners consumption was a GDM risk factor in BMI-stratified analyses.

Conclusion: High consumption of artificial sweeteners, like sucralose, aspartame, and sodium saccharin, is linked to increased risk of GDM in pregnant women. Further research is required to confirm results and explore mechanism, guiding healthy eating habits during pregnancy.

妊娠期人工甜味剂摄入与妊娠期糖尿病发病率的相关性分析。
背景:不良的饮食习惯是孕妇发生妊娠期糖尿病(GDM)的高危因素。GDM会影响母亲和孩子的健康。随着食品加工的发展,孕妇不可避免地会食用人工甜味剂,其中最常见的三种是三氯蔗糖、阿斯巴甜和糖精钠。怀孕期间食用人工甜味剂是否会增加妊娠糖尿病的风险是一个值得关注的问题。目的:分析妊娠期人工甜味剂摄入与GDM发病率的关系。方法:对广东省某医院422名孕妇进行方便抽样调查。问卷收集了一般信息、人工甜味剂的消费量以及其他与GDM相关的因素。根据国际糖尿病与妊娠研究小组协会(IADPSG)的规定,妊娠期间任何时间通过75g口服葡萄糖耐量试验(OGTT)诊断为GDM。人造甜味剂的消费量按四分制分为低消费量和高消费量两类。采用多因素logistic回归模型控制混杂因素,分析人工甜味剂用量与gdm之间的关系。结果:本研究纳入422例孕妇,平均年龄(32±3.73)岁,GDM发病率为13.74%。人工甜味剂高摄食组GDM发生率为56.90%,低摄食组为43.10% (p < 0.05)。人工甜味剂摄入量增加与GDM风险增加有关(OR=2.66,95% CI: 1.48-1.78)。在bmi分层分析中,高人工甜味剂摄入量是GDM的危险因素。结论:大量食用人工甜味剂,如三氯蔗糖、阿斯巴甜和糖精钠,与孕妇患糖尿病的风险增加有关。需要进一步的研究来证实结果和探索机制,指导怀孕期间的健康饮食习惯。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信